Oasis Peptides
Semaglutide
Finnrick tested 4 samples of Semaglutide (GLP-1 antagonist) from Oasis Peptides between 14 Jan 2025 and 13 Feb 2025. Tests score average over 0, no score below 0, and at least 2 tests warrant a tentative Finnrick Rating of E (Bad).
Finnrick Rating™
Oasis Peptides
Semaglutide
Tested 4 Samples
Last test 13 Feb 2025
Take Action
Mail in a Sample
We test your peptides for free: mail in a sample you have (US only), or request us to test a vendor.
Semaglutide is also available from top-rated vendors:
All Semaglutide tests from Oasis Peptides
Samples are tested in commercial labs
Tests Count
4
Scores
AVGMINMAX
Last
13 Feb 2025
First
14 Jan 2025
| Quantity | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Test Date | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 13 Feb 2025 | 5mg | 5.943mg | +18.9% | 99.06% | (no batch ID) | (no data) | Lab C | Finnrick | |
| 13 Feb 2025 | 5mg | 5.875mg | +17.5% | 99.03% | (no batch ID) | (no data) | Lab C | Finnrick | |
| 23 Jan 2025 | 5mg | 5.350mg | +7.0% | 93.35% | (no batch ID) | (no data) | Lab B | Finnrick | |
| 14 Jan 2025 | 5mg | 5.638mg | +12.8% | 96.65% | (no batch ID) | (no data) | Lab A | Finnrick | |